Wealthspire Advisors (New York)’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
MIP
Wealthspire Advisors (New York)'s SNY Position: Q1 2026 in Review
Wealthspire Advisors (New York) sold out of Sanofi (SNY) in Q1 2026, closing a stake of 5,624 shares — an estimated $273K sold.
Wealthspire Advisors (New York) first reported a position in SNY in Q4 2018 and held it in 11 quarters. The position peaked at $573K in Q1 2020. 740 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- Wealthspire Advisors (New York) reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
- Wealthspire Advisors (New York) sold 5,624 Sanofi shares in Q1 2026, an estimated $273K.
- Wealthspire Advisors (New York) first reported a position in Sanofi in Q4 2018 and held it in 11 quarters.
- Wealthspire Advisors (New York)'s Sanofi position peaked at $573K in Q1 2020.
- 740 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.